[(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate

C26H41NO8 — CID 177466363

IUPAC[(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate
SMILESCCN1C[C@]2(COC)CC[C@H](O)[C@@]34[C@@H]5C[C@H]6[C@H](OC(C)=O)[C@@H]5[C@](OC)(C[C@@H]6OC)[C@](O)([C@H](O)[C@H]23)[C@@H]14
InChIInChI=1S/C26H41NO8/c1-6-27-11-23(12-32-3)8-7-17(29)25-15-9-14-16(33-4)10-24(34-5,18(15)19(14)35-13(2)28)26(31,22(25)27)21(30)20(23)25/h14-22,29-31H,6-12H2,1-5H3/t14-,15-,16+,17+,18-,19+,20-,21-,22+,23+,24-,25+,26+/m1/s1
InChIKeyHINPWIIQKPVUTQ-YVRQVPSMSA-N
MW495.61 g/mol
LogP0.19
Rot. Bonds6

About [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate

[(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate (PubChem CID 177466363) has the molecular formula C26H41NO8 and a molecular weight of 495.61 g/mol. Its IUPAC name is [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate.

Molecular Properties

Compound Name[(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate
PubChem CID177466363
Molecular FormulaC26H41NO8
Molecular Weight495.61 g/mol
Exact Mass495.28
IUPAC Name[(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate
SMILESCCN1C[C@]2(COC)CC[C@H](O)[C@@]34[C@@H]5C[C@H]6[C@H](OC(C)=O)[C@@H]5[C@](OC)(C[C@@H]6OC)[C@](O)([C@H](O)[C@H]23)[C@@H]14
InChIInChI=1S/C26H41NO8/c1-6-27-11-23(12-32-3)8-7-17(29)25-15-9-14-16(33-4)10-24(34-5,18(15)19(14)35-13(2)28)26(31,22(25)27)21(30)20(23)25/h14-22,29-31H,6-12H2,1-5H3/t14-,15-,16+,17+,18-,19+,20-,21-,22+,23+,24-,25+,26+/m1/s1
InChIKeyHINPWIIQKPVUTQ-YVRQVPSMSA-N
XLogP0.19
TPSA117.92 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms35
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500495.61
LogP ≤ 50.19
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Analyze [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate?
The IUPAC name of [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate (CID 177466363) is [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate.
What is the SMILES notation for [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate?
The canonical SMILES for [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate is CCN1C[C@]2(COC)CC[C@H](O)[C@@]34[C@@H]5C[C@H]6[C@H](OC(C)=O)[C@@H]5[C@](OC)(C[C@@H]6OC)[C@](O)([C@H](O)[C@H]23)[C@@H]14.
What is the InChIKey of [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate?
The InChIKey is HINPWIIQKPVUTQ-YVRQVPSMSA-N. The full InChI is InChI=1S/C26H41NO8/c1-6-27-11-23(12-32-3)8-7-17(29)25-15-9-14-16(33-4)10-24(34-5,18(15)19(14)35-13(2)28)26(31,22(25)27)21(30)20(23)25/h14-22,29-31H,6-12H2,1-5H3/t14-,15-,16+,17+,18-,19+,20-,21-,22+,23+,24-,25+,26+/m1/s1.
What are the key properties of [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate?
[(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate has a molecular weight of 495.61 g/mol, XLogP of 0.19, 6 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,2R,3R,4S,5R,6S,8R,9R,10S,13S,16S,17R,18R)-11-ethyl-9,16,18-trihydroxy-6,8-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] acetate is sourced from PubChem (CID 177466363), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).